Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Extended trial tests acromegaly Pill's Long-Term safety

NCT ID NCT04261712

Summary

This study follows patients with acromegaly who previously participated in earlier trials of the oral medication paltusotine. The main goal is to monitor long-term safety and side effects of continued treatment. Researchers will also track hormone levels to see if the drug continues to control the condition over time.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACROMEGALY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Crinetics Study Site

    Los Angeles, California, 90095, United States

  • Crinetics Study Site

    Chicago, Illinois, 60611, United States

  • Crinetics Study Site

    Boston, Massachusetts, 02114, United States

  • Crinetics Study Site

    Columbus, Ohio, 43210, United States

  • Crinetics Study Site

    Pittsburgh, Pennsylvania, 15212, United States

  • Crinetics Study Site

    Pittsburgh, Pennsylvania, 15213, United States

  • Crinetics Study Site

    Dallas, Texas, 75231, United States

  • Crinetics Study Site

    Curitiba, Paraná, 80030-110, Brazil

  • Crinetics Study Site

    Rio de Janeiro, 20231, Brazil

  • Crinetics Study Site

    Rio de Janeiro, 21941, Brazil

  • Crinetics Study Site

    São Paulo, 01228, Brazil

  • Crinetics Study Site

    München, 80336, Germany

  • Crinetics Study Site

    Athens, 10676, Greece

  • Crinetics Study Site

    Thessaloniki, 54642, Greece

  • Crinetics Study Site

    Budapest, 1062, Hungary

  • Crinetics Study Site

    Budapest, 1083, Hungary

  • Crinetics Study Site

    Pécs, 7624, Hungary

  • Crinetics Study Site

    Belgrade, 11000, Serbia

  • Crinetics Study Site

    Coventry, United Kingdom

  • Crinetics Study Site

    Leeds, LS97TF, United Kingdom

  • Crinetics Study Site 1

    Athens, 11527, Greece

  • Crinetics Study Site 2

    Athens, 11527, Greece

Conditions

Explore the condition pages connected to this study.